1. Zuazo-Gaztelu, I, Casanovas, O (2018) Unraveling the role of angiogenesis in cancer ecosystems. Front Oncol 8: 248.
Google Scholar | Crossref | Medline2. Modi, SJ, Kulkarni, VM (2019) Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective. Med Drug Discov 2: 100009.
Google Scholar | Crossref3. Muhammad Sakri, MS, Wan Abdul Rahman, WF, Tengku Din, TA, Mohd Idris, F, Jaafar, H (2020) Microvessel density and vascular endothelial growth factor receptors in breast carcinoma under the influence of rapamycin and platelet factor 4. Indian J Pathol Microbiol 63: 205–209.
Google Scholar | Crossref | Medline4. Veli-Matti, L, Kari, A (2018) Vascular endothelial growth factor signaling in development and disease Sinem Karaman. Development 145: dev151019.
Google Scholar | Crossref | Medline5. Bower, NI, Vogrin, AJ, Guen, LL, et al. (2017) Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development. Development 114: 507–518.
Google Scholar6. Parveen, A, Subedi, L, Kim, HW, et al. (2019) Phytochemicals targeting VEGF and VEGF-related multifactors as anticancer therapy. J Clin Med 8: 350.
Google Scholar | Crossref7. Cao, M, Tang, Y, Zhang, W, Tang, Y, Liang, X (2019) Non-coding RNAs as regulators of lymphangiogenesis in lymphatic development, inflammation, and cancer metastasis. Front Oncol 9: 916.
Google Scholar | Crossref | Medline8. Li, J, Kim, SG, Blenis, J (2014) Rapamycin: one drug, many effects. Cell Metabol 19(3): 373–379.
Google Scholar | Crossref | Medline9. Tunçer Vural, A, Karataş Toğral, A, Güleç, AT, Haberal, M (2018) Kaposi sarcoma in the era of rapamycin remains a therapeutic challenge in organ transplant recipients. Exp Clin Transplant 16(1): 25–27.
Google Scholar | Medline10. Pilatova, K, Greplova, K, Demlova, R, Bencsikova, B, Klement, G, Zdrazilova-Dubska (2013) Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. J Hematol Oncol 6: 42.
Google Scholar | Crossref | Medline11. Bikfalvi, A (2004) Platelet factor 4: an inhibitor of angiogenesis. Semin Thromb Hemost 30(3): 379–385.
Google Scholar | Crossref | Medline12. Li, C, Jiang, W, Zhou, Y, Huang, X, Zhou, N (2020) PF-4V1 affects the progression of oral squamous cell carcinoma by regulating Wnt/β-catenin pathway and angiogenesis. Appl Biol Chem 63: 18.
Google Scholar | Crossref13. Jaafar, H, Idris, FM, Nafi, SNM (2009) The association between phenotype and size of breast tumors induced by 1-methyl-1-nitrosourea (MNU) injection in rats. Med Sci Monitor 15: 129–134.
Google Scholar | ISI14. Nowak-Sliwinska, P, Alitalo, K, Allen, E, et al. (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21: 425–532.
Google Scholar | Crossref | Medline15. Bustin, SA, Benes, V, Garson, JA, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611–622.
Google Scholar | Crossref | Medline | ISI16. Vandesompele, J, De Preter, K, Pattyn, F, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: 1.
Google Scholar | Crossref17. Al-Rawi, MAA, Jiang, WG (2011) Lymphangiogenesis and cancer metastasis. Front Biosci 16: 723–739.
Google Scholar | Crossref18. Singla, A, Gupta, N, Apewokin, S, McCormack, FX (2017) Sirolimus for the treatment of lymphangioleiomyomatosis. Expert Opinion on Orphan Drugs 5: 907–921.
Google Scholar | Crossref19. Kowalska, MA, Rauova, L, Poncz, M (2010) Role of the platelet chemokine platelet factor-4 (PF-4) in hemostasis and thrombosis. Thromb Res 125: 292–296.
Google Scholar | Crossref | Medline | ISI20. Matkar, PN, Ariyagunarajah, R, Leong-Poi, H, Singh, KK (2017) Friends turned foes: angiogenic growth factors beyond angiogenesis. Biomolecules 7: 74.
Google Scholar | Crossref | Medline21. Castro, PR, Barbosa, AS, Pereira, JM, et al. (2018) Cellular and molecular heterogeneity associated with vessel formation processes. BioMed Res Int 32: 6740408.
Google Scholar22. Yoon, MS (2017) The role of mammalian target of rapamycin (mTOR) in insulin signaling. Nutrients 9: 1176–1192.
Google Scholar | Crossref23. Caccuri, F, Bugatti, A, Corbellini, S, et al. (2019) The synthetic dipeptide pidotimod shows a chemokine-like activity through CXC chemokine receptor 3 (CXCR3). Int J Mol Sci 20: 5287.
Google Scholar | Crossref24. Lugano, R, Ramachandran, M, Dimberg, A (2019) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77: 1745–1770. DOI: 10.1007/s00018-019-03351-7
Google Scholar | Crossref | Medline25. Niu, G, Chen, X (2010) Vascular endothelial growth factor as an antiangiogenic target for cancer therapy. Curr Drug Targets 11: 1000–1017.
Google Scholar | Crossref | Medline26. Hsu, M-C, Pan, M-R, Hung, W-C (2019) Two birds, one stone: double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3. Cells 8: 270.
Google Scholar | Crossref27. Charan, J, Kantharia, ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4(4): 303–306.
Google Scholar | Crossref | Medline28. Gheni, N, Westenberg, D (2020) Quantitative real-time PCR assay with immunohistochemical evaluation of HER2/neu oncogene in breast cancer patients and its correlation with clinicopathological findings. Indian J Pathol Microbiol 63: S123–S128.
Google Scholar | Crossref | Medline